Cargando…

New Onset Multiple Sclerosis Post-COVID-19 Vaccination and Correlation With Possible Predictors in a Case-Control Study

Introduction: Various inflammatory diseases have been associated with the administration of various vaccines. Several reports have associated vaccine administration with the demyelinating diseases of the central nervous system (CNS). However, no clear or strong scientific evidence exists to support...

Descripción completa

Detalles Bibliográficos
Autor principal:	Alluqmani, Majed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108897/ https://www.ncbi.nlm.nih.gov/pubmed/37077605 http://dx.doi.org/10.7759/cureus.36323

Ejemplares similares

Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination
por: Czarnowska, Agata, et al.
Publicado: (2023)

The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms
por: Fernández, Óscar, et al.
Publicado: (2020)

Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapy
por: Melnikov, Mikhail, et al.
Publicado: (2022)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset
por: Tao, Chunrong, et al.
Publicado: (2018)

Neural Correlates of Outcome Anticipation in Multiple Sclerosis
por: Spirou, Angela, et al.
Publicado: (2018)

Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors
por: Ajdacic-Gross, Vladeta, et al.
Publicado: (2021)

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
por: Margoni, Monica, et al.
Publicado: (2021)

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

The Potential for EBV Vaccines to Prevent Multiple Sclerosis
por: Maple, Peter A., et al.
Publicado: (2022)

New-Onset Chorea Post-COVID-19 Infection: A Case Report
por: Grimm, Benjamin G, et al.
Publicado: (2023)

Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide
por: Tornatore, Carlo, et al.
Publicado: (2022)

Hepatitis B Vaccine and Multiple Sclerosis: Cause or Coincidence
por: Luhadia, Kunjal, et al.
Publicado: (2022)

Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
por: Maniscalco, Giorgia T., et al.
Publicado: (2021)

Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2018)

Driving ability and predictors for driving performance in Multiple Sclerosis: A systematic review
por: Seddiq Zai, Susan, et al.
Publicado: (2022)

New-Onset Neurologic Symptoms and Related Neuro-Oncologic Lesions Discovered After COVID-19 Vaccination: Two Neurosurgical Cases and Review of Post-Vaccine Inflammatory Responses
por: Einstein, Evan H, et al.
Publicado: (2021)

Multiple Sclerosis Masquerading as Post Septorhinoplasty Complication: A Case Report
por: Alolayet, Dana, et al.
Publicado: (2021)

Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets
por: Moiola, Lucia, et al.
Publicado: (2022)

Cranial Nerve Enhancement in Multiple Sclerosis Is Associated With Younger Age at Onset and More Severe Disease
por: Haider, Lukas, et al.
Publicado: (2019)

New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine
por: Abicic, Ana, et al.
Publicado: (2022)

Development of Cortical Lesion Volumes on Double Inversion Recovery MRI in Patients With Relapse-Onset Multiple Sclerosis
por: Faizy, Tobias D., et al.
Publicado: (2019)

Early-Onset Multiple Sclerosis With Frequent Relapses: A Challenging Diagnosis With a Less Favorable Prognosis
por: Thadchanamoorthy, Vijayakumary, et al.
Publicado: (2021)

Predictors of Evolution Into Multiple Sclerosis After a First Acute Demyelinating Syndrome in Children and Adolescents
por: Papetti, Laura, et al.
Publicado: (2019)

Synaptic Loss in Multiple Sclerosis: A Systematic Review of Human Post-mortem Studies
por: Möck, E. E. Amelie, et al.
Publicado: (2021)

Demographic and Clinical Predictors of Disease Severity in Patients With Multiple Sclerosis: A Retrospective Cross-Sectional Analysis
por: Almuklass, Awad M, et al.
Publicado: (2023)

The Distributional Characteristics of Multiple Sclerosis Lesions on Quantitative Susceptibility Mapping and Their Correlation With Clinical Severity
por: Guo, Zhuoxin, et al.
Publicado: (2021)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?
por: Negron, Austin, et al.
Publicado: (2020)

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
por: Quintanilla-Bordás, Carlos, et al.
Publicado: (2022)

Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland
por: Czarnowska, Agata, et al.
Publicado: (2022)

New Insights Into Immune Cell-Derived Extracellular Vesicles in Multiple Sclerosis
por: Blonda, Maria, et al.
Publicado: (2018)

Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT(®) Autoinjector: A Prospective Observational Cohort Study
por: Köhler, Wolfgang, et al.
Publicado: (2021)

Bulbar Onset Amyotrophic Lateral Sclerosis in a COVID-19 Patient: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

Identification of Cortical and Subcortical Correlates of Cognitive Performance in Multiple Sclerosis Using Voxel-Based Morphometry
por: Matías-Guiu, Jordi A., et al.
Publicado: (2018)

The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis
por: Motolese, Francesco, et al.
Publicado: (2020)

Multiple Sclerosis Patient Management During the COVID-19 Pandemic: Practical Recommendations From the Portuguese Multiple Sclerosis Study Group (GEEM)
por: Cerqueira, João J., et al.
Publicado: (2021)

A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis?
por: Schirò, Giuseppe, et al.
Publicado: (2022)

Restless leg syndrome in multiple sclerosis: a case–control study
por: Aljarallah, Salman, et al.
Publicado: (2023)

Deciphering Multiple Sclerosis Progression
por: Meca-Lallana, Virginia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iup3sttpb4kfhl5f4jkqqllc05